Localized Cancer Immunotherapy

Unlimited.

Localized.

An injectable gel that keeps potent immunotherapy inside the tumor, where it works, and out of the bloodstream, where it harms.

Immunotherapy.

Our Vision


Immunotherapy has revolutionized cancer care, but it has not reached it’s potential because it is dose-limited.

Limited benefit

~20%

of patients benefit from systemic checkpoint immunotherapy

Severe toxicity

~40%

of patients experience immune-related toxicities that may interrupt therapy

Lasting toxicity

~35%

of patients suffer long-term side effects that require ongoing management


Intratumoral injections can deliver concentrated drug to the tumor with reduced systemic exposure, but conventional injections are inconsistent and unpredictable.


Injectable gels ensure on-target delivery and sustained drug release.

“The does makes the poison”, and so does the delivery.

XCSgel is a chitosan-based hydrogel that flows through a fine needle, then re-forms a gel inside the tumor. It releases its payload slowly and is broken down naturally by the body.

Our lead product, IT-001, pairs XCSgel with IL-12, a powerful immune-activating cytokine that proved too toxic when given systemically.

XCSgel holds the dose in place.

Saline injection

Leaks along the needle track and away from the target

XCSgel injection

Gels on contact and stays where it’s placed